300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Sports
Legal
Biotechnology
eSports
Construction
Consumer
Renewable Energy
Software
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
LGBT
Celebrity
Climate
Fashion
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Social
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Beauty
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Infrastructure
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Costa Rica
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Canada
United Kingdom
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database

CDTI Innovación's INNVIERTE program

VC Fund

Madrid, Spain

CDTI Innovación's INNVIERTE program is a VC fund in Madrid focused on Biotechnology and Health Care. CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.

Total investments:
52
Last investment:
Lead investor:
37%

Last updated:

Industries CDTI Innovación's INNVIERTE program invests in

BiotechnologyHealth CareMedicalSoftwareLife Science

Stages CDTI Innovación's INNVIERTE program invests in

Venture - Series UnknownSeedFunding RoundGrantSeries A

Countries CDTI Innovación's INNVIERTE program invests in

SpainPanamaSwitzerland

Round sizes

Seed $266k–$6.4MVenture - Series Unknown $330k–$16M

Round size

Seed
$266k–$6.4M
Venture - Series Unknown
$330k–$16M

Investment Focus

Industry

  • Biotechnology 14 (27%)
  • Health Care 9 (17%)
  • Medical 7 (13%)
  • Software 5 (10%)
  • Life Science 4 (8%)
See all 70 industries →

Stage

  • Venture - Series Unknown 18 (35%)
  • Seed 16 (31%)
  • Funding Round 4 (8%)
  • Grant 3 (6%)
  • Series A 3 (6%)
See all 7 stages →

Country

  • Spain 41 (79%)
  • Panama 1 (2%)
  • Switzerland 1 (2%)

Investments

CompanyDescriptionRoundLinks
Telum Therapeutics Telum Therapeutics
Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages. $20.5M / Series A / Jul 01, 2026
Ona Therapeutics Ona Therapeutics
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine. $86.6M / Series B / Jun 04, 2026
Zoundream Zoundream
Babies cry sounds convey a massive stream of information: its needs, emotions, well-being, and physical status. Indeed, it’s the only way small babies have to communicate with the external world.In Zoundream, we use cutting edge developments in sound recognition, to the specific field of baby cries. Our technology can not only translate cries inreal time (e.g. hungry, sleepy), but also identify potential pathologies – improving well-being of families and babies, all around the world. $761.5K / Venture - Series Unknown / May 05, 2026
MOA MOA
MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food. Venture - Series Unknown / Apr 27, 2026
LuxQuanta LuxQuanta
Bringing quantum-safe cryptography to the Telecommunication industry $1M / Venture - Series Unknown / Apr 13, 2026
Golden Owl Golden Owl
Golden Owl is an AI-powered business intelligence platform that delivers real-time insights through AI agents and open-source intelligence. It provides AI-driven business intelligence and risk analysis using a network of specialized AI agents. The platform gathers and analyzes open-source data to help organizations monitor markets, competitors,threats, and opportunities. It enables faster decision-making through automated intelligence collection, analytics, and conversational AI-powered insights. Grant / Apr 09, 2026
Molecular Gate Molecular Gate
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease. $526.3K / Seed / Mar 02, 2026
Orikine Bio Orikine Bio
Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders. $3.2M / Seed / Feb 02, 2026
Padmi Padmi
Padmi is an artificial intelligence mobile application that serves technological assistance and support for individual internet users. $961.6K / Venture - Series Unknown / Jan 30, 2026
Polimerbio Polimerbio
A new generation of materials for biomedical devices that improve the quality of life and an efficient medicine. $528.4K / Venture - Series Unknown / Dec 17, 2025
See all 52 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
Oil and Gas
InsurTech
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Sports
Legal
Biotechnology
eSports
Construction
Consumer
Renewable Energy
Software
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Cannabis
LGBT
Celebrity
Climate
Fashion
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Social
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Beauty
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Infrastructure
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Costa Rica
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Canada
United Kingdom
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does CDTI Innovación's INNVIERTE program invest in?

CDTI Innovación's INNVIERTE program invests primarily in Biotechnology, Health Care and Medical startups, most often at Venture - Series Unknown and Seed stage. Most of the 52 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is CDTI Innovación's INNVIERTE program's check size?

CDTI Innovación's INNVIERTE program typically joins rounds of $266k–$6.4M at Seed and $330k–$16M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds CDTI Innovación's INNVIERTE program participates in.

When did CDTI Innovación's INNVIERTE program last invest?

The most recent investment recorded for CDTI Innovación's INNVIERTE program closed in Jul 2026. Shizune tracks 52 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
CDTI Innovación's INNVIERTE program Find emails